Erasca, Inc. (ERAS) Misses Q1 EPS by 49c

Erasca, Inc. (NASDAQ: ERAS) reported Q1 EPS of ($0.60), $0.49 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Erasca, Inc. (ERAS) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c